Latest news with #Certara
Yahoo
6 days ago
- Business
- Yahoo
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing
NEW YORK, May 29, 2025--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced the expansion of its leadership team with the appointment of Mannix Aklian as executive vice president, chief commercial officer, global head of software sales and marketing. Mr. Aklian brings more than 25 years of experience in software sales and leadership roles within the biopharmaceutical and technology industries. Mr. Aklian will have global oversight of Schrödinger's account management teams and will be responsible for the continued growth of the company's software business, including the go-to-market strategy for enhancements and new products within Schrödinger's computational platform. "Mannix joins Schrödinger at a pivotal time as we continue to drive scale-up and adoption of our industry-leading computational platform, and he will be instrumental in building upon our strong foundation of scientific excellence and customer success," stated Ramy Farid, Ph.D., chief executive officer of Schrödinger. "Mannix's extensive experience in sales leadership, combined with his deep understanding of the power of computation in drug discovery make him incredibly well-suited to deliver on our software growth goals, and we look forward to his contributions to the company." "I am thrilled to join the talented Schrödinger team," said Mannix Aklian. "Schrödinger's commitment to transforming molecular discovery through computation aligns with my passion for delivering innovative solutions that can increase efficiency in the industry. I look forward to realizing the significant business opportunity Schrödinger has in both life sciences and materials science." Mr. Aklian joins Schrödinger from Certara, where he served as senior vice president, global software sales. In this role, Mr. Aklian led a global team of professionals in sales and operations and provided executive leadership, strategic business development, and execution of software commercialization for Certara's technology platforms. He drove sales and revenue growth globally, expanding into new market segments through strategic partnerships. Prior to Certara, Mr. Aklian was chief executive officer of LI, Inc., an enterprise software company serving the pharmaceutical industry. He led software development, commercialization and full platform operations at LI, Inc., leading the creation and deployment of multiple mobile and desktop applications. Mr. Aklian previously held sales and commercial operations roles at Molecular Devices, LLC and Corning Incorporated. He holds a B.S. in Molecular Biology and an M.S. in Molecular Biology and Biotechnology, both from Tufts University. About SchrödingerSchrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit follow us on LinkedIn and Instagram, or visit our blog, Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 including, but not limited to those statements regarding Schrödinger's expectations about the speed and capacity of its computational platform, the long-term potential of its business, and its ability to scale-up software use by its customers and grow its software business. Statements including words such as "aim," "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "goal," "intend," "may," "might," "plan," "potential," "predict," "project," "should," "target," "will," "would" and statements in the future tense are forward-looking statements. These forward-looking statements reflect Schrödinger's current views about its plans, intentions, expectations, strategies and prospects, which are based on the information currently available to the company and on assumptions the company has made. Actual results may differ materially from those described in these forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and important factors that are beyond Schrödinger's control, including the demand for its software platform, its ability to further develop its computational platform, its reliance upon third-party providers of cloud-based infrastructure to host its software solutions, the ability to retain and hire key personnel and other risks detailed under the caption "Risk Factors" and elsewhere in the company's Securities and Exchange Commission filings and reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Securities and Exchange Commission on May 7, 2025, as well as future filings and reports by the company. Any forward-looking statements contained in this press release speak only as of the date hereof. Except as required by law, Schrödinger undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, changes in expectations or otherwise. View source version on Contacts Matthew Luchini (Investors) 917-719-0636 Allie Nicodemo (Media) 617-356-2325 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Technical.ly
27-05-2025
- Business
- Technical.ly
This Week in Jobs: Pour yourself some Java and check out these 20 tech career opportunities
This week, we're returning, once again, to the year 1995. It was May 27, 30 years ago to the day, and Sun Microsystems released a programming language called Oak, running a demo of interactive content in Netscape Navigator at SunWorld '95. Due to a trademark issue, it wouldn't be known as Oak for long. Its new name? Java. Java, with its 'Write Once, Run Anywhere' philosophy, changed both software development and web browsers — Java applets, tiny programs that enhanced web pages beyond what simple HTML could do, enabled things like animations, interactive charts, and file processing. Java was quickly adopted by enterprise and became one of the largest software languages, driving ecosystems, banking systems and Android apps. Today, 15 years after Sun Microsystems was acquired by Oracle, Java is still the dominant language for enterprise backend applications. If you're searching for a job at a financial institution or large corporation, you likely have Java certification. Whatever your coding language of choice, let's get to the job listings. The News is getting a new reporter: Meet Baltimore County's Maria Eberhart. Experts debate how to handle AI's role in US-China relations at Johns Hopkins University forum. Pittsburgh Public Schools weigh adoption of a $2 million deal with a Philly startup to upgrade its cafeteria logistics. How machine learning can help prevent burnout in healthcare workers. . Client Spotlight Certara has a truly global footprint, and is a leader in biosimulation, model-informed drug development and clinical trial data standardization and workflow automation. The company has proven a draw for technologists who prefer autonomy and thrive on the challenge of doing application development in a highly specialized scientific domain. The Jobs Greater Philly The City of Philadelphia is hiring an Information Technology Support Coordinator. Drexel University has a job listing for a Web Support Specialist. Software company Certara is seeking a Senior Software Engineer. Dental technology company Kleer and Membersy needs an Integration Engineer. MetaTechnical in Narberth is hiring an IT Support Technician. DC + Baltimore Startup investor Techstars is looking for an Investment Manager in DC. Coworking space Spark Baltimore is seeking a Community Manager. Enoch Pratt Free Library has an opening for a Digital Equity Coordinator who will be a member of the Department of Innovation and Technology. Brooksource needs a Business Analyst. DataAnnotation is looking for Data Engineers to help train AI models. Pittsburgh Allegheny County is hiring an Information Systems Specialist. Professional services firm KPMG has a listing for Marketing Cloud Technical Lead. Bridgeway in Coraopolis is seeking an IT Service and Support Specialist. Westco needs a hybrid IT Technology Lead. GE Vernova is hiring for . The End Those are the jobs — get yourself to a cup of joe and apply.
Yahoo
27-02-2025
- Business
- Yahoo
Certara Inc (CERT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions
Total Revenue: $385.1 million for the full year 2024, representing 9% growth year-over-year. Fourth Quarter Revenue: $100.4 million, a 14% increase year-over-year. Fourth Quarter Bookings: $144.5 million, up 22% from the prior year. Software Revenue: $42.3 million in Q4, a 26% increase year-over-year. Full Year Software Revenue: $155.7 million, an 18% increase year-over-year. Services Revenue: $58.1 million in Q4, a 7% increase year-over-year. Full Year Services Revenue: $229.5 million, a 3% increase year-over-year. Adjusted EBITDA: $33.5 million in Q4, with a margin of 33%. Full Year Adjusted EBITDA: $122.0 million, with a margin of 32%. Net Income: $6.6 million in Q4, compared to a net loss of $12.5 million in Q4 2023. Adjusted Net Income: $24.7 million in Q4, compared to $14.3 million in Q4 2023. Diluted EPS: $0.04 in Q4, compared to a loss of $0.08 per share in Q4 2023. Adjusted Diluted EPS: $0.15 in Q4, compared to $0.09 in Q4 2023. Cash and Cash Equivalents: $179.2 million as of December 31, 2024. 2025 Revenue Guidance: $415 million to $425 million, representing 8% to 10% growth. 2025 Adjusted EBITDA Margin Guidance: 30% to 32%. 2025 Adjusted EPS Guidance: $0.42 to $0.46 per share. Warning! GuruFocus has detected 3 Warning Sign with VINP. Release Date: February 26, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Certara Inc (NASDAQ:CERT) achieved a 9% revenue growth in 2024, reaching $385.1 million, with strong performance in both software and services. Fourth-quarter bookings increased by 22% year-over-year, driven by a 38% growth in software bookings and a 12% growth in services bookings. The company successfully integrated recent acquisitions, including Chemaxon, which contributed $6.6 million to fourth-quarter revenue. Certara expanded its customer base to over 2,400 life sciences companies, with significant growth in customers with annual contract values exceeding $100,000 and $1 million. Certara's focus on biosimulation and model-informed drug development (MIDD) continues to gain traction, with strong adoption across the biopharmaceutical industry. Certara faced cautious spending behavior from customers due to funding constraints, Medicare drug price negotiations, and geopolitical uncertainties. Decision-making timelines among customers have been elongated, impacting the predictability of demand for Certara's services. The software net retention rate decreased to 106% in the fourth quarter, attributed to spending patterns and slower decision-making among Tier 1 customers. Regulatory writing revenue declined in 2024, although it showed signs of recovery in the fourth quarter. Certara's guidance for 2025 assumes a similar market environment to 2024, with potential challenges in clinical R&D spending and customer decision-making processes. Q: Can you explain the factors that could lead Certara to achieve the high or low end of its 2025 revenue guidance? A: John Gallagher, CFO, explained that achieving the high end of the guidance would depend on improvements in end markets, particularly with Tier 1 and Tier 3 customers. Tier 1 customers are experiencing spending patterns impacted by layoffs and portfolio prioritization, while Tier 3 customers are taking longer to make decisions after receiving funding. If these conditions improve, Certara could reach the higher end of the guidance range; if they worsen, the company might hit the lower end. Q: What are the planned R&D investments for 2025, and how do they relate to Chemaxon? A: John Gallagher, CFO, stated that Certara plans to invest in R&D to maintain momentum in its software portfolio and AI initiatives. The integration of Chemaxon is ongoing, and the company expects to align Chemaxon's margins with Certara's by the end of the year. The investments are aimed at enhancing product development and integrating Chemaxon's capabilities with Certara's existing assets. Q: How is Certara expanding its market share and customer wallet share? A: William Feehery, CEO, noted that Certara's investments in new products and updates have led to positive customer feedback and increased sales. The company is focusing on expanding its software suite, particularly in AI and core products like Simcyp and Pinnacle 21, to open new market opportunities and increase its share of customer spending. Q: What is the impact of the new administration on Certara's business? A: William Feehery, CEO, mentioned that Certara is monitoring the new administration's policies for potential opportunities and risks. However, it is too early to make definitive plans or pronouncements as the situation is still developing. Q: Can you provide more details on the CoAuthor product and its market potential? A: William Feehery, CEO, highlighted that CoAuthor has multiple paying customers and a strong pipeline. The product reduces the time to create regulatory documents significantly and is expected to generate millions in revenue this year. Certara plans to expand CoAuthor's capabilities and document types, leveraging AI to enhance its functionality. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
